434-16-2 Usage
Description
7-dehydro Cholesterol (7-DHC) is an immediate precursor of cholesterol. It is reduced to cholesterol by the enzyme 3β-hydroxysterol-Δ7-reductase (DHCR7) in the last step of cholesterol biosynthesis. 7-DHC accumulates in Smith-Lemli-Opitz syndrome (SLOS), a disorder characterized by a mutation in the DHCR7 gene and decreased cholesterol levels in bodily tissues and fluids, as well as microcephaly, intellectual disability, and distinctive dysmorphic features. It is highly susceptible to free radical oxidation, giving rise to several oxysterols that may be involved in the pathogenesis of SLOS. 7-DHC levels are increased in brain, liver, and serum in a rat model of SLOS induced by the DHCR7 inhibitor AY 9944 . 7-DHC is a provitamin that is converted to vitamin D3 by ultraviolet-B (UVB) light in a human skin equivalent system and in isolated human skin samples.
Chemical Properties
white to off-white fine crystalline powder
Uses
Different sources of media describe the Uses of 434-16-2 differently. You can refer to the following data:
1. A vitamin precursor.
Vitamin D3 is produced by the action of sunlight or ultraviolet irradiation from the precursor, 7-dehydrocholesterol (7-DC), that is synthesized in the skin of animals and humans.
In most tissues of the body, 7-dehydrocholesterol is the immediate precursor of cholesterol. It is reduced to cholesterol by the enzyme 3β-hydroxysterol-Δ7-reductase (DHCR7) in the last step of cholesterol biosynthesis. 7-DHC accumulates in Smith-Lemli-Opitz syndrome (SLOS), a disorder characterized by a mutation in the DHCR7 gene and decreased cholesterol levels in bodily tissues and fluids, as well as microcephaly, intellectual disability, and distinctive dysmorphic features. It is highly susceptible to free radical oxidation, giving rise to several oxysterols that may be involved in the pathogenesis of SLOS. 7-DHC levels are increased in brain, liver, and serum in a rat model of SLOS induced by the DHCR7 inhibitor AY 9944. 7-DHC is a provitamin that is converted to vitamin D3 by ultraviolet-B (UVB) light in a human skin equivalent system and in isolated human skin samples.
2. 7-Dehydrocholesterol (7-DHC), a 5,7-conjugated diene sterol is a biosynthetic precursor of cholesterol. It helps in the production of vitamin D3 when exposed to ultraviolet B (UVB) radiation. 7-Dehydrocholesterol has been used as an internal standard to determine sterols.
7-dehydrocholesterol is used in the diagnosis of Smith-Lemli-Opitz syndrome. Blood and tissue of infants with Smith- Lemli-Opitz (SLO) syndrome contain reduced amounts of cholesterol and greatly increased concentrations of 7-dehydrocholesterol and of its isomer 8-dehydrocholesterol.
3. A vitamin D3 precursor.
General Description
7-Dehydrocholesterol (7-DHC), a 5,7-conjugated diene sterol is a biosynthetic precursor of cholesterol. It helps in the production of vitamin D3 when exposed to ultraviolet B (UVB) radiation.
Biochem/physiol Actions
Down-regulates cholesterol biosynthesis in cultured Smith-Lemi-Opitz syndrome skin fibroblasts.
Check Digit Verification of cas no
The CAS Registry Mumber 434-16-2 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 4,3 and 4 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 434-16:
(5*4)+(4*3)+(3*4)+(2*1)+(1*6)=52
52 % 10 = 2
So 434-16-2 is a valid CAS Registry Number.
InChI:InChI=1/C27H44O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h9-10,18-19,21,23-25,28H,6-8,11-17H2,1-5H3/t19-,21+,23-,24+,25+,26+,27-/m1/s1
434-16-2Relevant articles and documents
Oxidation of cholesterol by a biomimetic oxidant, cetyltrimethylammonium dichromate
Patel, Sabita,Mishra
, p. 3522 - 3526 (2006)
The oxidation of cholesterol by cetyltrimethylammonium dichromate (CTADC) in dichloromethane (DCM) yielded 7-dehydrocholesterol, while with addition of acetic acid in DCM the product was found to be 5-cholesten-3-one. The kinetics of oxidation of cholesterol by CTADC in DCM, in the presence of acid, was investigated with change in [acid], [cholesterol], [CTADC], [surfactant], temperature, and solvents. The reaction was found to be first order with acetic acid and fractional order with CTADC and cholesterol. Michaelis-Menten-type kinetics was observed with respect to cholesterol. The solvent isotope effect was found to be k(D2O)/k(H2O) = 0.72. The observed experimental data suggest that the reaction occurs in reversed micellar system, akin to an enzymatic environment, and the reaction path involves the intermediate formation of an ester complex, which undergoes decomposition to give the product.
IMPROVED, COST EFFECTIVE PROCESS FOR SYNTHESIS OF VITAMIN D3 AND ITS ANALOGUE CALCIFEDIOL FROM ERGOSTEROL
-
Page/Page column 23; 43, (2021/01/29)
Disclosed herein is an improved and efficient process for synthesis of vitamin D3 and its analogue Calcifediol from Ergosterol. Particularly, the present invention discloses the synthesis of key intermediate 3β-tert-Butyldimethylsilyloxy-22-hydroxy-23,24-bisnorchola-5,7-diene (5), and novel intermediate β-tert-Butyldimethylsilyloxy-22-iodo-23,24-bisnorchola-5,7-diene (9) by a simple and cost effective process. The industrially viable processes for preparation of said intermediate(s) results in providing provitamins with various side chains and the desired products in high yield.
PREPARATION OF 7-DEHYDROCHOLESTEROL USING SPECIFIC AROMATIC SOLVENTS
-
, (2021/10/30)
The present invention relates to a new synthesis of 7- dehydrocholesterol or itsOH-protected forms of the formula I by the reaction of a compound of formula (ll)in the presence of a solvent of formula (III), comprising the step (a) wherein a salt of the formula (II) is added to a solvent of the formula (III) at a temperature of between 60 °C and the boiling point of said solvent. This process leads to a significant reduction in the level of the by-product of formula (V).
